get a key
steadybase-$ company MBRX
account_id none on file
legal_name Moleculin Biotech, Inc.
ticker MBRX
cik 1659617
domain moleculin.com
entry_point_account_id none on file
name Moleculin Biotech Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 6 executives 6 family 0
why_nownone on file
callsnone on file
filings
This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

filing / Aug 24, 2026 / receipt

on assets; net asset turnover; inventory turnover; return on capital or return on invested capital; return on equity; cash flow; net or pre-tax income; profit margin; working capital turns; market share; expense management; revenue; revenue growth; stockholder equity; leverage ratio; investment rating; debt coverage; the achievement of clinical milestones; and the achievement of technological milestones.

filing / Aug 24, 2026 / receipt

of businesses or assets by the Company; litigation, judgments or settlements; changes in tax laws, accounting principles, or other laws or provisions affecting reported results; any reorganization and restructuring programs; unusual and/or non-recurring items; and fluctuations in foreign exchange rates.

filing / Aug 24, 2026 / receipt

Walter V. Klemp serves as both our Chief Executive Officer and Chairman of the Board.

filing / Aug 24, 2026 / receipt

Our Board of Directors currently consists of five members: Walter V. Klemp, Robert George, John Climaco, Michael Cannon, and Elizabeth Cermak.

filing / Aug 24, 2026 / receipt

Dr. Joy Yan resigned from the Board of Directors effective August 10, 2026.

filing / Aug 24, 2026 / receipt

executives
familynone on file
upcoming
2026-11-12 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$